Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

H Storgaard, J Sivertsen - Diabetes, Obesity and Metabolism, 2017 - Wiley Online Library
Aims To investigate the effects of exercise in combination with a glucagon‐like peptide‐1
receptor agonist (GLP‐1RA), liraglutide, or placebo for the treatment of type 2 diabetes …
被引用次数：48 相关文章
[HTML] nih.gov

[HTML][HTML] Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

P Mensberg, S Nyby, PG Jørgensen… - Diabetes, Obesity & …, 2017 - ncbi.nlm.nih.gov
Aims To investigate the effects of exercise in combination with a glucagon‐like peptide‐1
receptor agonist (GLP‐1RA), liraglutide, or placebo for the treatment of type 2 diabetes …

[引用][C] Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

saxo.ku.dk
Aims: Exercise as well as glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment
improves glycaemic control in patients with type 2 diabetes. We investigated the effects of …

Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

P Mensberg, S Nyby, PG Jørgensen… - Diabetes, Obesity and …, 2017 - infona.pl
Aims To investigate the effects of exercise in combination with a glucagon‐like peptide‐1
receptor agonist (GLP‐1RA), liraglutide, or placebo for the treatment of type 2 diabetes …

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

P Mensberg, S Nyby, PG Jørgensen… - Diabetes, Obesity …, 2017 - research.regionh.dk
AIMS: To investigate the effects of exercise in combination with a glucagon-like peptide-1
receptor agonist (GLP-1RA), liraglutide, or placebo for the treatment of type 2 diabetes …

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

tors.ku.dk
Aims: Exercise as well as glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment
improves glycaemic control in patients with type 2 diabetes. We investigated the effects of …

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

komm.ku.dk
Aims: Exercise as well as glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment
improves glycaemic control in patients with type 2 diabetes. We investigated the effects of …

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes.

P Mensberg, S Nyby, PG Jørgensen… - Diabetes, Obesity & …, 2017 - search.ebscohost.com
Aims To investigate the effects of exercise in combination with a glucagon-like peptide-1
receptor agonist (GLP-1RA), liraglutide, or placebo for the treatment of type 2 diabetes …

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes.

P Mensberg, S Nyby, PG Jørgensen… - Diabetes, Obesity & …, 2016 - europepmc.org
Aims To investigate the effects of exercise in combination with a glucagon-like peptide-1
receptor agonist (GLP-1RA), liraglutide, or placebo for the treatment of type 2 diabetes …

Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

P Mensberg, S Nyby, PG Jørgensen, H Storgaard… - 2017 - pubmed.ncbi.nlm.nih.gov
Aims To investigate the effects of exercise in combination with a glucagon-like peptide-1
receptor agonist (GLP-1RA), liraglutide, or placebo for the treatment of type 2 diabetes …